Study of Novel StAR Mutations in Adrenal Hyperplasia
Author Information
Author(s): Flück Christa E., Pandey Amit V., Dick Bernhard, Camats Núria, Fernández-Cancio Mónica, Clemente María, Gussinyé Miquel, Carrascosa Antonio, Mullis Primus E., Audi Laura
Primary Institution: Pediatric Endocrinology and Diabetology, University Children's Hospital Bern, Bern, Switzerland
Hypothesis
StAR gene mutations causing partial loss of function manifest atypical and may be mistaken as familial glucocorticoid deficiency.
Conclusion
Two novel StAR mutations were identified, with one causing a milder, non-classic phenotype.
Supporting Evidence
- StAR gene analysis revealed two novel compound heterozygote mutations T44HfsX3 and G221S.
- G221S retains partial activity (∼30%) and is responsible for a milder, non-classic phenotype.
- The study raises the number of families with reported late-onset, nonclassic CLAH with StAR mutations to over 10.
Takeaway
This study found two new mutations in a gene that helps produce hormones, which can cause health issues in children.
Methodology
The study involved genetic analysis of the StAR gene in two siblings diagnosed with adrenal insufficiency.
Limitations
The study is limited by the small sample size and the need for further investigation into the long-term effects of the mutations.
Participant Demographics
Two subjects from a non-consanguineous Caucasian family.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website